HealthDay - TUESDAY, Aug. 4 (HealthDay News) — Drugs widely used to fight
rheumatoid arthritis, Crohn’s disease and other inflammatory disorders
must now carry an updated “black box” warning label cautioning patients
and doctors that the medicines may boost cancer risk in children and
adolescents, the U.S. Food and Drug Administration announced Tuesday.